Delivery Order SPE2DB22D3004-SPE2DB25FRU59
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a contract value of $1,780.51. This competitively awarded, firm fixed price delivery order is set to be completed by July 28, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and is issued as a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $1,922.04 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and is being performed at the contractor's Conshohocken, Pennsylvania location. The award is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Brilinta 90 mg tablets (60-count units) valued at $3,168.70 under a firm fixed price contract. This delivery order was competitively awarded without set-aside designation and is set to be completed by August 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,552.14 to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count packaging). This firm fixed-price, competitively awarded contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,044.86 and is classified as a non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,720.95 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) under a firm fixed-price contract type. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.39 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,169.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. This order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and was competitively awarded....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on August 5, 2025, with a ceiling value of $1,468.41. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a contract ceiling value of $3,541.70. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRU59Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $2,167.73. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 4, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The SPE2DX vehicle functions as a comprehensive global pharmaceutical support contract enabling the company to supply a vast range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains. The contract supports military healthcare programs worldwide and serves customers including the Defense Health Agency and U.S. Coast Guard. Brilinta is a cardiovascular medication commonly used in military medical supply chains, and this delivery order reflects routine pharmaceutical replenishment under the broader vendor relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/1/25 |